Cryptobiotix

Cryptobiotix is a preclinical CRO specialising in the gastrointestinal tract and the gut microbiome, both for humans and animals. Its validated ex vivo SIFR® technology pipeline is a modular platform that simulates the full gastrointestinal tract and delivers predictive, clinically relevant insights, for many products and individuals at the same time.

By combining scalability with demonstrated predictivity for clinical outcomes, the Systemic Intestinal Fermentation Research (SIFR) technology helps bridge the gap between preclinical data and real-world responses. The platform captures inter-individual variability, enabling mechanistic understanding of how test products interact with diverse gut microbiota in a controlled ex vivo setting.

Cryptobiotix provides research services for functional ingredients and therapeutic products across the foodtech, biotech and pharmaceutical sectors. Typical applications include prebiotics, probiotics, postbiotics, synbiotics, sweeteners, medical foods, whole foods and active pharmaceutical ingredients.

From early R&D screening to in-depth mechanistic characterisation, study designs are tailored to specific research questions in order to generate decision-grade data. This supports faster and de-risked development of gut health solutions and microbiome-targeted innovations.